Clinical Trial Update: To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH) [Phase 2]

View source ↗

Summary

Phase 2 TOUCH trial updates results on reducing chemotherapy use in postmenopausal patients with ER-positive and HER2-positive breast cancer. Results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Breast Cancer, Estrogen Receptor Positive Tumor | Phase 2 | Status: COMPLETED | Results posted: 2024-12-13